The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 45 | — | 20.1x | Near average | |
Growth | 87 | 553.2% | 5.6% | Above average | |
Quality | 86 | 30.5% | 7.6% | Above average | |
Safety | 93 | -3.9x | 0.4x | Above average | |
Capital Return | 21 | — | 2.19% | Below average | |
Momentum | 94 | — | — | Above average | |
Sentiment | 48 | — | — | Near average |
Nanobiotix S.A. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Nanobiotix S.A. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Nanobiotix (NBTX) stock has seen an upward revision in its average price target, rising from $26 to $30 over the past 30 days, an increase of 15.38%. This rise is primarily due to an increase in the number of analysts covering the stock from one to three, with total consensus (Zero Dispersion) at the $30 level, reflecting a unified future vision among research institutions such as H.C. Wainwright and Cowen & Co, which maintained a 'Buy' rating.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.